347: More HHS upheaval, 23andMe's bankruptcy, and AI for cancer survival
The Readout Loud
00:00
Intro
This chapter explores recent advancements in the biotech sector, focusing on AI's role in enhancing cancer treatment and the contrasting human approaches. It discusses significant news such as proposed job cuts in health agencies, a new treatment approval for a rare disease, and the bankruptcy of 23andMe, along with insights from an AI startup founder on tumor detection.
Transcript
Play full episode
